130 related articles for article (PubMed ID: 37310574)
41. Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension.
Yasuda M; Takayama K; Kanda T; Taguchi M; Someya H; Takeuchi M
PLoS One; 2017; 12(10):e0185305. PubMed ID: 28968412
[TBL] [Abstract][Full Text] [Related]
42. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.
Lam DS; Fan DS; Ng JS; Yu CB; Wong CY; Cheung AY
Clin Exp Ophthalmol; 2005 Jun; 33(3):252-8. PubMed ID: 15932528
[TBL] [Abstract][Full Text] [Related]
43. Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases.
Miyazaki D; Shimizu D; Fukushima A; Ebihara N; Uchio E; Shoji J; Namba K; Inoue Y; Ohashi Y; Okamoto S; Takamura E; Fujishima H
Jpn J Ophthalmol; 2020 Nov; 64(6):568-576. PubMed ID: 33026594
[TBL] [Abstract][Full Text] [Related]
44. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
[TBL] [Abstract][Full Text] [Related]
45. Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience.
Monsellato R; Trovato E; Turchetti P; Forestiere M; Pistone A; De Sio S; Accetta L; Pacella F
Clin Ter; 2020; 170(1):e11-e14. PubMed ID: 31850478
[TBL] [Abstract][Full Text] [Related]
46. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.
De Moerloose B; Suciu S; Bertrand Y; Mazingue F; Robert A; Uyttebroeck A; Yakouben K; Ferster A; Margueritte G; Lutz P; Munzer M; Sirvent N; Norton L; Boutard P; Plantaz D; Millot F; Philippet P; Baila L; Benoit Y; Otten J;
Blood; 2010 Jul; 116(1):36-44. PubMed ID: 20407035
[TBL] [Abstract][Full Text] [Related]
47. Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber.
Perry HD; Donnenfeld ED; Acheampong A; Kanellopoulos AJ; Sforza PD; D'Aversa G; Wallerstein A; Stern M
CLAO J; 1998 Jul; 24(3):159-65. PubMed ID: 9684074
[TBL] [Abstract][Full Text] [Related]
48. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Rix M; Birkebaek NH; Rosthøj S; Clausen N
J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
[TBL] [Abstract][Full Text] [Related]
49. OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.
Reid GA; Sahota DS; Sarhan M
Retina; 2015 Aug; 35(8):1647-55. PubMed ID: 25932545
[TBL] [Abstract][Full Text] [Related]
50. Steroid-induced ocular hypertension in the pediatric age group.
Al Hanaineh AT; Hassanein DH; Abdelbaky SH; El Zawahry OM
Eur J Ophthalmol; 2018 Jul; 28(4):372-377. PubMed ID: 29554813
[TBL] [Abstract][Full Text] [Related]
51. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Qin Y; Lam S; Yam GH; Choy KW; Liu DT; Chiu TY; Li WY; Lam DS; Pang CP; Fan DS
Acta Ophthalmol; 2012 Sep; 90(6):559-63. PubMed ID: 21044276
[TBL] [Abstract][Full Text] [Related]
52. Incidence of steroid-induced ocular hypertension after vitreoretinal surgery with difluprednate versus prednisolone acetate.
Jeng KW; Fine HF; Wheatley HM; Roth D; Connors DB; Prenner JL
Retina; 2014 Oct; 34(10):1990-6. PubMed ID: 25121927
[TBL] [Abstract][Full Text] [Related]
53. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
[TBL] [Abstract][Full Text] [Related]
54. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
[TBL] [Abstract][Full Text] [Related]
55. SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy.
Groth SL; Albeiruti E; Nunez M; Fajardo R; Sharpsten L; Loewen N; Schuman JS; Goldberg JL
Ophthalmology; 2019 Nov; 126(11):1511-1516. PubMed ID: 31444008
[TBL] [Abstract][Full Text] [Related]
56. Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.
Bakk I; Koch T; Stanek J; O'Brien SH; Reed S
J Pediatr Hematol Oncol; 2018 Jan; 40(1):27-30. PubMed ID: 29189508
[TBL] [Abstract][Full Text] [Related]
57. Severe vernal keratoconjunctivitis requiring trabeculectomy with mitomycin C for corticosteroid-induced glaucoma.
Ang M; Ho CL; Tan D; Chan C
Clin Exp Ophthalmol; 2012; 40(4):e149-55. PubMed ID: 21575117
[TBL] [Abstract][Full Text] [Related]
58. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
[TBL] [Abstract][Full Text] [Related]
59. Association of OCT angle recess width with IOP response after intravitreal triamcinolone injection.
Singer MA; Groth SL; Sponsel WE; Herro A; Pollard J; Cohen SR; Cohen JH
Retina; 2013 Feb; 33(2):282-6. PubMed ID: 22846803
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy.
Tekeli O; Köse HC
Turk J Ophthalmol; 2022 Aug; 52(4):262-269. PubMed ID: 36017234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
